William Duke

William Duke is a seasoned financial executive with extensive experience in leadership roles across various organizations. As of September 2023, William serves as Chief Financial Officer at Invivyd, following a similar role at Apexigen from June 2022 to August 2023. Previous positions include Chief Financial Officer at Kaleido Biosciences, Pulmatrix Inc., and Valeritas, showcasing a continuous trajectory of increased responsibilities. William's earlier career features roles such as Senior Director of Finance at Genzyme and Director of Finance/Accounting at Haemonetics Corporation, with an initial position as Senior Financial Analyst at NerveWire, Inc. Educational credentials include a Bachelor of Science in Business Administration with a focus in Accounting from Stonehill College and an MBA in Finance from Bentley University.